BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 36540922)

  • 21. Prognostic Value of Preoperative Serum Calcitonin Levels for Predicting the Recurrence of Medullary Thyroid Carcinoma.
    Park H; Park SY; Park J; Choe JH; Chung MK; Woo SY; Choi JY; Kim SW; Chung JH; Kim TH
    Front Endocrinol (Lausanne); 2021; 12():749973. PubMed ID: 34675884
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ultrasonographic Features of Medullary Thyroid Carcinoma: Do they Correlate with Pre and PostOperative Calcitonin Levels?
    Cho KE; Gweon HM; Park AY; Yoo MR; Kim J; Youk JH; Park YM; Son EJ
    Asian Pac J Cancer Prev; 2016; 17(7):3357-62. PubMed ID: 27509975
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk Factors Associated With Reoperation and Disease-Specific Mortality in Patients With Medullary Thyroid Carcinoma.
    Kuo EJ; Sho S; Li N; Zanocco KA; Yeh MW; Livhits MJ
    JAMA Surg; 2018 Jan; 153(1):52-59. PubMed ID: 28973144
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The survival outcomes of prophylactic lateral neck dissection for medullary thyroid carcinoma, a retrospective cohort study.
    Hao W; Zhao J; Guo F; Zhang J; Gu P; Ruan X; Zhang W; Zheng X; Gao M
    Clin Otolaryngol; 2023 Sep; 48(5):734-739. PubMed ID: 37366234
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic significance of extranodal extension of regional lymph node metastasis in papillary thyroid cancer.
    Wu MH; Shen WT; Gosnell J; Duh QY
    Head Neck; 2015 Sep; 37(9):1336-43. PubMed ID: 24821456
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rationale for central and bilateral lymph node dissection in sporadic and hereditary medullary thyroid cancer.
    Scollo C; Baudin E; Travagli JP; Caillou B; Bellon N; Leboulleux S; Schlumberger M
    J Clin Endocrinol Metab; 2003 May; 88(5):2070-5. PubMed ID: 12727956
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Medullary thyroid carcinoma with nodular goiter carries an excellent prognosis.
    Xu L; Wang WB; Zhao YP; Zhang TP; Liao Q; Chen G; Zhou L; Shu H
    J Surg Oncol; 2012 Aug; 106(2):169-73. PubMed ID: 22354558
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Medullary thyroid carcinoma: clinical characteristics, treatment, prognostic factors, and a comparison of staging systems.
    Kebebew E; Ituarte PH; Siperstein AE; Duh QY; Clark OH
    Cancer; 2000 Mar; 88(5):1139-48. PubMed ID: 10699905
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lymph Node Ratio as a Predictive Factor of Persistent/Recurrent Disease in Patients With Medullary Thyroid Cancer: A Single-Center Retrospective Study.
    Prinzi A; Frasca F; Russo M; Le Moli R; Belfiore A; Malandrino P
    Endocr Pract; 2024 Mar; 30(3):194-199. PubMed ID: 38008257
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CALCITONIN SECRETORY INDEX AND UNSUSPECTED NODAL DISEASE IN MEDULLARY THYROID CARCINOMA.
    Filimon S; Payne RJ; Black MJ; Hier MP; Mlynarek AM; Forest VI; Tamilia M
    Endocr Pract; 2018 May; 24(5):460-467. PubMed ID: 29847167
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preoperative basal calcitonin and tumor stage correlate with postoperative calcitonin normalization in patients undergoing initial surgical management of medullary thyroid carcinoma.
    Yip DT; Hassan M; Pazaitou-Panayiotou K; Ruan DT; Gawande AA; Gaz RD; Moore FD; Hodin RA; Stephen AE; Sadow PM; Daniels GH; Randolph GW; Parangi S; Lubitz CC
    Surgery; 2011 Dec; 150(6):1168-77. PubMed ID: 22136837
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor Grade Predicts for Calcitonin Doubling Times and Disease-Specific Outcomes After Resection of Medullary Thyroid Carcinoma.
    Nigam A; Xu B; Spanheimer PM; Ganly I; Tuttle RM; Wong RJ; Shaha AR; Ghossein RA; Untch BR
    Thyroid; 2022 Oct; 32(10):1193-1200. PubMed ID: 35950622
    [No Abstract]   [Full Text] [Related]  

  • 33. Medullary thyroid cancer outcomes in patients with undetectable versus normalized postoperative calcitonin levels.
    Fanget F; Demarchi MS; Maillard L; Lintis A; Decaussin M; Lifante JC
    Br J Surg; 2021 Sep; 108(9):1064-1071. PubMed ID: 33899100
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PROGNOSTIC VARIABLES AFFECTING PRIMARY TREATMENT OUTCOME FOR MEDULLARY THYROID CANCER.
    Momin S; Chute D; Burkey B; Scharpf J
    Endocr Pract; 2017 Sep; 23(9):1053-1058. PubMed ID: 28683235
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incidental T1 stage medullary thyroid carcinoma: The effect of tumour diameter on prognosis and therapeutic implications.
    Gui Z; Wang Z; Xiang J; Sun W; He L; Dong W; Huang J; Zhang D; Lv C; Zhang T; Shao L; Zhang P; Zhang H
    Clin Endocrinol (Oxf); 2022 Sep; 97(3):355-362. PubMed ID: 35192214
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Nationwide Study of Multiple Endocrine Neoplasia Type 2A in Norway: Predictive and Prognostic Factors for the Clinical Course of Medullary Thyroid Carcinoma.
    Opsahl EM; Brauckhoff M; Schlichting E; Helset K; Svartberg J; Brauckhoff K; Mæhle L; Engebretsen LF; Sigstad E; Grøholt KK; Akslen LA; Jørgensen LH; Varhaug JE; Bjøro T
    Thyroid; 2016 Sep; 26(9):1225-38. PubMed ID: 27400880
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preoperative identification of low-risk medullary thyroid carcinoma: potential application to reduce total thyroidectomy.
    Park H; Ryu HJ; Heo J; Chung MK; Son YI; Kim JH; Hahn SY; Shin JH; Oh YL; Kim SW; Chung JH; Kim JS; Kim TH
    Sci Rep; 2023 Sep; 13(1):15663. PubMed ID: 37730953
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early Diagnosis of Medullary Thyroid Cancer: Are Calcitonin Stimulation Tests Still Indicated in the Era of Highly Sensitive Calcitonin Immunoassays?
    Niederle MB; Scheuba C; Riss P; Selberherr A; Koperek O; Niederle B
    Thyroid; 2020 Jul; 30(7):974-984. PubMed ID: 32056502
    [No Abstract]   [Full Text] [Related]  

  • 39. Combining serum calcitonin, carcinoembryonic antigen, and neuron-specific enolase to predict lateral lymph node metastasis in medullary thyroid carcinoma.
    Ye L; Zhou X; Lu J; Wang Y; Xie X; Zhang J
    J Clin Lab Anal; 2020 Jul; 34(7):e23278. PubMed ID: 32141647
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changing trends in the clinicopathological features and clinical outcomes of medullary thyroid carcinoma.
    Kwon H; Kim WG; Sung TY; Jeon MJ; Song DE; Lee YM; Yoon JH; Chung KW; Hong SJ; Baek JH; Lee JH; Kim TY; Shong YK; Kim WB
    J Surg Oncol; 2016 Feb; 113(2):152-8. PubMed ID: 26799259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.